PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Mefenamic Acid”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 901 records · Page 50Linked to original sources

Characterization of an outward potassium current in canine jejunal circular smooth muscle and its activation by fenamates.

1. A perforated patch clamp technique was used to study an outward potassium current in freshly dissociated circular smooth muscle cells of the canine jejunum. 2. A voltage-dependent outward current was identified which was highly potassium selective, weakly holding voltage sensitive, increased its open probability at -65 mV, and reached unit open probability at +5 mV. 3. Quinidine (0.1-1 mM) and tetraethylammonium ion (TEA) (10-50 mM), blocked the potassium current in a dose-dependent manner. Blockade of the outward potassium current was accompanied by membrane depolarization which reversed on removal of the blocker from the bathing solution. 4. Mefenamic and flufenamic acids, non-steroidal anti-inflammatory agents in the fenamate group, were potent activators of the current. Activation was accompanied by hyperpolarization of the membrane with a mean shift in the membrane voltage of 22 mV. 5. It was concluded that the outward potassium current is a major regulator of the resting membrane voltage in isolated circular smooth muscle cells of the canine jejunum. Fenamates activated this current with potentially profound effects on cellular excitability.

Animals↗

[Mechanism of formation of blocking factors and method of antiblocking immunotherapy in malignant tumors].

A hypothesis on blocking factor formation in carcinogenesis is discussed. Destabilisation of cell membranes and increased levels of proteolytic enzymes in tumor tissue are considered to be the trigger mechanism. Protease level in large bowel tumor was found to be higher than in normal tissue. Plasminogen level in cancer patients was significantly higher than in healthy subjects. Application of different experimental schemes of treatment with membrane-stabilizing drugs and an inhibitor of protease was followed by antitumor and antiblocking effects. Sorption of rheumatoid factor and immune complexes from plasma led to a decrease in the blocking activity of plasma in vitro. In cases of rectal cancer, plasmapheresis was followed by tumor regression and a fall in immune complex concentration.

2,3-Diketogulonic Acid↗

[Quantification of menstrual bleeding in women using intrauterine devices (IUDs)].

A study in the changes of menstrual blood loss produced by the of 11 different intrauterine devices (IUDs) in 319 voluntary women attending a voluntary program for Family Planning at the Instituto Mexicano del Seguro Social (IMSS). The results showed that two IUDs increased bleeding above 80 mL in the case of Lippes Loop D and the copper T 380. The following IUDs: Cu T 200 and 220, as well as ML-250 increased blood loss moderately; copper 7 produced a slightly higher blood loss (not statistically significant) "T" IUDs liberating progesterone or progestagens (Nor 8; Nor 2; Net 10) all produce a significant decrease of the menstural flow, reaching 93.5% (of the control value) in women using "T" IUDs liberating 8 micrograms of Levonorgestrel. Excessive bleeding in women with IUDs (over 80 ml) is checked significantly by the use of non-steroid anti-inflammatory prostaglandin synthesis' inhibitors such as 500 mg of mefenaminc acid or 250 mg of Naproxen thrice daily for 5 days.

Female↗